Recombinant Human GIPC1 Protein, N-His from ProteoGenix; catalogue ARO-P12227; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human GIPC1 Protein is a type of protein that is produced through genetic engineering techniques, where the gene encoding for the protein is inserted into a host organism, such as bacteria or yeast, to produce large quantities of the protein. This protein is a member of the GIPC family of proteins, which are known to play important roles in cellular signaling and protein trafficking.
Recombinant Human GIPC1 Protein is a 76 kDa protein that consists of 668 amino acids. It contains several domains, including a PDZ domain, a coiled-coil domain, and a C-terminal domain. The PDZ domain is responsible for protein-protein interactions, while the coiled-coil domain is involved in protein dimerization. The C-terminal domain is important for the localization and function of the protein.
Recombinant Human GIPC1 Protein is known to play a crucial role in intracellular signaling pathways. It has been shown to interact with several proteins, including receptors, enzymes, and cytoskeletal proteins, through its PDZ domain. These interactions are important for the regulation of various cellular processes, such as cell growth, differentiation, and survival.
One of the key functions of Recombinant Human GIPC1 Protein is its role in protein trafficking. It has been shown to be involved in the transport of proteins from the Golgi apparatus to the plasma membrane, as well as in the internalization of cell surface receptors. This activity is important for maintaining the proper distribution and function of proteins within the cell.
Furthermore, Recombinant Human GIPC1 Protein has been found to be involved in the regulation of cell adhesion and migration. It interacts with proteins that are important for the formation of adhesion complexes, which are crucial for cell-cell and cell-matrix interactions. This activity is important for various physiological processes, such as tissue development, wound healing, and immune response.
Recombinant Human GIPC1 Protein has a wide range of applications in both research and therapeutic settings. Its role in cellular signaling and protein trafficking makes it a valuable tool for studying various cellular processes. It can be used to investigate the interactions between proteins and their role in different signaling pathways. Additionally, Recombinant Human GIPC1 Protein can be used to study the effects of mutations or modifications on protein function.
In a therapeutic context, Recombinant Human GIPC1 Protein has been studied for its potential role in cancer treatment. It has been found to be overexpressed in several types of cancer, and its inhibition has been shown to reduce tumor growth and metastasis. This makes it a potential target for developing novel cancer therapies.
Moreover, Recombinant Human GIPC1 Protein has been studied for its role in neurological disorders, such as Alzheimer’s disease and Parkinson’s disease. It has been found to interact with proteins involved in the formation of amyloid plaques, which are characteristic of these diseases. This suggests that targeting Recombinant Human GIPC1 Protein could potentially have therapeutic benefits for these conditions.
In summary, Recombinant Human GIPC1 Protein is a 76 kDa protein with a complex structure that plays important roles in cellular signaling, protein trafficking, and cell adhesion. Its wide range of interactions and functions make it a valuable tool for studying various cellular processes and a potential target for therapeutic interventions in diseases such as cancer and neurological disorders. Further research on this protein could lead to a better understanding of its role in different physiological and pathological processes, and potentially pave the way for the development of new treatments.
ProteoGenix catalogue number ARO-P12227. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 32.53 kDa; Fragment: Phe60-Tyr333; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
